New prospects of cancer therapy based on pyroptosis and pyroptosis inducers
- 9 November 2023
- journal article
- review article
- Published by Springer Nature in Apoptosis
- Vol. 29 (1-2) , 66-85
Abstract
Pyroptosis is a gasdermin-mediated programmed cell death (PCD) pathway. It differs from apoptosis because of the secretion of inflammatory molecules. Pyroptosis is closely associated with various malignant tumors. Recent studies have demonstrated that pyroptosis can either inhibit or promote the development of malignant tumors, depending on the cell type (immune or cancer cells) and duration and severity of the process. This review summarizes the molecular mechanisms of pyroptosis, its relationship with malignancies, and focuses on current pyroptosis inducers and their significance in cancer treatment. The molecules involved in the pyroptosis signaling pathway could serve as therapeutic targets for the development of novel drugs for cancer therapy. In addition, we analyzed the potential of combining pyroptosis with conventional anticancer techniques as a promising strategy for cancer treatment.Keywords
Funding Information
- National Natural Science Foundation of China (81803916)
- Natural Science Foundation of Jiangsu Province (BK20180128)
This publication has 201 references indexed in Scilit:
- CD14 Targets Complement Receptor 3 to Lipid Rafts during Phagocytosis of Borrelia burgdorferiInternational Journal of Biological Sciences, 2013
- A quarter century of granzymesCell Death & Differentiation, 2011
- IL-18 Induces PD-1–Dependent Immunosuppression in CancerCancer Research, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- IL-18 Production Downstream of the Nlrp3 Inflammasome Confers Protection against Colorectal Tumor FormationThe Journal of Immunology, 2010
- The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA virusesNature Immunology, 2010
- Glucosamine inhibits IL‐1β‐mediated IL‐8 production in prostate cancer cells by MAPK attenuationJournal of Cellular Biochemistry, 2009
- Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinomaOncogene, 2008
- Dendritic Cells Phagocytose and Are Activated byTreponema pallidumInfection and Immunity, 2001
- On the Origin of Cancer CellsScience, 1956